ATH 16.7% 0.5¢ alterity therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

  1. 2,011 Posts.
    lightbulb Created with Sketch. 515
    as expected cash balance at the end of this raise will be circa ~18m, with at least a 4m r&d refund so that gives ath approx 22m cash runway for 2024. with positive data and options exercised, that should give us (hopefully) enough cash to develop and implement the next step forward after p2 top line data available.

    if it wasnt for the opportunity potential on the addressable market combined with recent indication of positive efficacy for ath434, i would say the risk is too much.

    in any case i was able to tap and fund 2 shareholders for indirect participation of their shares so thats two parcels of 15k each subscribed for under the spp for 2 shareholders alone. i would expect the shortfall to be at a minimum or nill. seems a bit silly to me not to have participated if there is further interest in those shares.

    bottom drawer now and see you all at the next big announcement.

    gltah and dyor
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
-0.001(16.7%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.6¢ 0.6¢ 0.5¢ $3.421K 620.6K

Buyers (Bids)

No. Vol. Price($)
72 66250969 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 11640945 11
View Market Depth
Last trade - 16.10pm 09/05/2024 (20 minute delay) ?
Last
0.6¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
0.6¢ 0.6¢ 0.6¢ 441333
Last updated 14.07pm 09/05/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.